Latest filing published 05 Aug 2026 for Galera Therapeutics, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Lawrence M. Alleva is a declared insider at 4 companies (board member); the most frequent names are Bright Horizons Family Solutions Inc., Galera Therapeutics, Inc. and Mersana Therapeutics, Inc. Over a trading history stretching from 1 June 2021 to 3 August 2026, the count stands at 16 filings.
Market trades split into 3 purchases (€49k) and 1 sale (€55k). On balance, insiders were net sellers of €6,540. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants.
In size, the median ticket on the buying side is €12k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 5 August 2026 came the latest disclosure, a transaction in Galera Therapeutics, Inc. The last insider purchase was made public on 3 June 2021, 1,963 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations